119 related articles for article (PubMed ID: 31184612)
1. [Impedance Spectroscopy and Transcriptome Analysis of Choriocarcinoma BeWo b30 as a Model of Human Placenta].
Nikulin SV; Knyazev EN; Gerasimenko TN; Shilin SA; Gazizov IN; Zakharova GS; Poloznikov AA; Sakharov DA
Mol Biol (Mosk); 2019; 53(3):467-475. PubMed ID: 31184612
[TBL] [Abstract][Full Text] [Related]
2. Factors Involved in miRNA Processing Change Its Expression Level during Imitation of Hypoxia in BeWo b30 Cells.
Nersisyan SA; Shkurnikov MY; Knyazev EN
Dokl Biochem Biophys; 2020 Jul; 493(1):205-207. PubMed ID: 32894466
[TBL] [Abstract][Full Text] [Related]
3. Uptake and transport of pullulan acetate nanoparticles in the BeWo b30 placental barrier cell model.
Tang H; Jiang Z; He H; Li X; Hu H; Zhang N; Dai Y; Zhou Z
Int J Nanomedicine; 2018; 13():4073-4082. PubMed ID: 30034233
[TBL] [Abstract][Full Text] [Related]
4. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.
Ceckova M; Libra A; Pavek P; Nachtigal P; Brabec M; Fuchs R; Staud F
Clin Exp Pharmacol Physiol; 2006; 33(1-2):58-65. PubMed ID: 16445700
[TBL] [Abstract][Full Text] [Related]
5. Assessment of an in vitro transport model using BeWo b30 cells to predict placental transfer of compounds.
Li H; van Ravenzwaay B; Rietjens IM; Louisse J
Arch Toxicol; 2013 Sep; 87(9):1661-9. PubMed ID: 23689295
[TBL] [Abstract][Full Text] [Related]
6. In vitro placental model optimization for nanoparticle transport studies.
Cartwright L; Poulsen MS; Nielsen HM; Pojana G; Knudsen LE; Saunders M; Rytting E
Int J Nanomedicine; 2012; 7():497-510. PubMed ID: 22334780
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profile of a newly established choriocarcinoma cell line, iC3-1, compared to existing choriocarcinoma cell lines and normal placenta.
Kobayashi Y; Banno K; Shimizu T; Ueki A; Tsuji K; Masuda K; Kisu I; Nomura H; Tominaga E; Nagano O; Saya H; Aoki D
Placenta; 2013 Feb; 34(2):110-8. PubMed ID: 23199791
[TBL] [Abstract][Full Text] [Related]
8. Expression of membrane and nuclear progesterone receptors in two human placental choriocarcinoma cell lines (JEG-3 and BeWo): Effects of syncytialization.
Zachariades E; Foster H; Goumenou A; Thomas P; Rand-Weaver M; Karteris E
Int J Mol Med; 2011 Jun; 27(6):767-74. PubMed ID: 21455559
[TBL] [Abstract][Full Text] [Related]
9. Efflux transporter mRNA expression profiles in differentiating JEG-3 human choriocarcinoma cells as a placental transport model.
Ikeda K; Yamasaki K; Homemoto M; Yamaue S; Ogawa M; Nakao E; Fukunaga Y; Nakanishi T; Utoguchi N; Myotoku M; Hirotani Y
Pharmazie; 2012 Jan; 67(1):86-90. PubMed ID: 22393837
[TBL] [Abstract][Full Text] [Related]
10. Expression and activity of vitamin D receptor in the human placenta and in choriocarcinoma BeWo and JEG-3 cell lines.
Pospechova K; Rozehnal V; Stejskalova L; Vrzal R; Pospisilova N; Jamborova G; May K; Siegmund W; Dvorak Z; Nachtigal P; Semecky V; Pavek P
Mol Cell Endocrinol; 2009 Feb; 299(2):178-87. PubMed ID: 19133314
[TBL] [Abstract][Full Text] [Related]
11. IGF regulation of neutral amino acid transport in the BeWo choriocarcinoma cell line (b30 clone): evidence for MAP kinase-dependent and MAP kinase-independent mechanisms.
Fang J; Mao D; Smith CH; Fant ME
Growth Horm IGF Res; 2006; 16(5-6):318-25. PubMed ID: 17035059
[TBL] [Abstract][Full Text] [Related]
12. TMED2/p24β1 is expressed in all gestational stages of human placentas and in choriocarcinoma cell lines.
Zakariyah A; Hou W; Slim R; Jerome-Majewska L
Placenta; 2012 Mar; 33(3):214-9. PubMed ID: 22212250
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and secretion of human chorionic gonadotropin and its subunits in choriocarcinoma cells: a comparative study with normal placental cells.
Takeuchi Y; Sakakibara R; Ishiguro M
Mol Cell Endocrinol; 1990 Mar; 69(2-3):145-56. PubMed ID: 1691720
[TBL] [Abstract][Full Text] [Related]
14. Uptake mechanism of valproic acid in human placental choriocarcinoma cell line (BeWo).
Ushigome F; Takanaga H; Matsuo H; Tsukimori K; Nakano H; Ohtani H; Sawada Y
Eur J Pharmacol; 2001 Apr; 417(3):169-76. PubMed ID: 11334847
[TBL] [Abstract][Full Text] [Related]
15. Expression of mTOR and downstream signalling components in the JEG-3 and BeWo human placental choriocarcinoma cell lines.
Mparmpakas D; Zachariades E; Foster H; Kara A; Harvey A; Goumenou A; Karteris E
Int J Mol Med; 2010 Jan; 25(1):65-9. PubMed ID: 19956903
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific expression and thyroid hormone regulation of the endogenous placental growth hormone variant and chorionic somatomammotropin genes in a human choriocarcinoma cell line.
Nickel BE; Cattini PA
Endocrinology; 1991 May; 128(5):2353-9. PubMed ID: 1708334
[TBL] [Abstract][Full Text] [Related]
17. Studying placental transfer of highly purified non-dioxin-like PCBs in two models of the placental barrier.
Correia Carreira S; Cartwright L; Mathiesen L; Knudsen LE; Saunders M
Placenta; 2011 Mar; 32(3):283-91. PubMed ID: 21236486
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of L-alanine transport in a placental choriocarcinoma cell line (BeWo).
Moe AJ; Furesz TC; Smith CH
Placenta; 1994 Dec; 15(8):797-802. PubMed ID: 7886021
[TBL] [Abstract][Full Text] [Related]
19. Induction of cells differentiation and ABC transporters expression by a myco-estrogen, zearalenone, in human choriocarcinoma cell line (BeWo).
Prouillac C; Videmann B; Mazallon M; Lecoeur S
Toxicology; 2009 Sep; 263(2-3):100-7. PubMed ID: 19580841
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of stomatin causes syncytium formation in nonfusogenic JEG-3 choriocarcinoma placental cells.
Chen TW; Liu HW; Liou YJ; Lee JH; Lin CH
Cell Biol Int; 2016 Aug; 40(8):926-33. PubMed ID: 27306251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
